Antituberculosis agent-7 , CAS No.2874263-73-5

CAS: 2874263-73-5 Cat. No.: A1417372 Formule: C26H19F4NO3 Poids moléculaire: 469.43
DISPONIBLE À COMMANDE
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
USA
Allemagne (EU)*
Prix
Qté
1mg
A1417372-1mg
Sur commande · 8–12 semaines
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Antituberculosis agent-7, an oxetanyl-quinoline derivative, has shown good antibacterial activity against P. mirabilis with a MIC of 31.25 μM. Antituberculosis agent-7 shows good antifungal activity against A. niger with a MIC of 62.5 μM. Antituberculosis agent-7 shows excellent antimycobacterial activity with MIC 3.41 μM for M. tuberculosis H37Rv.

Spécifications

Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Type d'action
INHIBITOR
Noms et identifiants
Poids moléculaire
469.43

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

No vendor-validated applications are specified for this product. The following are general, non-item-specific workflows commonly used for small-molecule antitubercular research. Adjust to your institutional SOPs.

Example protocol A (MIC determination against M. tuberculosis; general):

  • Prepare a sterile 10–50 mM DMSO stock. Perform twofold serial dilutions in suitable broth (e.g., Middlebrook 7H9 + ADC) maintaining constant DMSO (≤0.5–1% v/v).
  • Inoculate to ~5×10^5 CFU/mL (verify by OD–CFU calibration). Incubate at 37 °C with appropriate containment. Readout after 7–14 days by OD600, resazurin reduction, or plating for CFU.
  • Report MIC as the lowest concentration with no visible growth or a predefined inhibition threshold.

Example protocol B (enzyme inhibition assay; general):

  • Dilute compound into assay buffer with matched vehicle controls. Include multiple concentrations (≥8-point curve). Measure initial rates and fit to derive IC50 with suitable models.

Controls and documentation:

  • Include media-only, vehicle, and positive-control inhibitor wells.
  • Record solvent %, lot numbers, and plate maps. Confirm compound identity/purity before pivotal experiments.

Note: These protocols are provided as general guidance and do not imply activity of this specific item.

Biological Roles

Item-specific biological targets or mechanisms are not provided for this compound. The name “Antituberculosis agent-7” indicates its inclusion in a discovery library oriented toward mycobacterial research.

General context (literature/general):

  • Mycobacterial viability depends on unique pathways, including mycolic acid biosynthesis (FAS-II system), arabinogalactan and peptidoglycan assembly, respiratory chain (e.g., cytochrome bc1-aa3), ATP synthase, and redox homeostasis (e.g., DprE1, InhA, MmpL3 pathways). Many screening hits modulate one or more of these.
  • Tool compounds with antitubercular activity are used to interrogate: cell wall integrity, efflux mechanisms, dormancy/persistence (e.g., hypoxia-induced nonreplicating states), and stress responses.
  • Chemogenomic and omics-based approaches (e.g., CRISPRi hypersensitivity profiling, metabolomics) can help assign putative modes of action to screening hits.

Good practices for biological evaluation (non-clinical):

  • Establish MIC values against relevant strains (e.g., M. tuberculosis H37Rv) under standardized conditions (inoculum density, media, incubation time) and report with solvent controls.
  • Assess bactericidal vs bacteriostatic behavior via time-kill kinetics.
  • Evaluate cytotoxicity counterscreens in mammalian cell lines to estimate selectivity windows.

Note: This section provides general background and does not imply any specific activity or target for this item. All functional attributions must be derived from your own experimental data with the supplied lot.

Buffer Applications

This product is a discrete small-molecule screening compound and is not a buffering agent. Therefore, classical buffer preparation guidance (pH range, buffer capacity) is not applicable.

Practical handling note (general):

  • When dosing into biological buffers, prepare a DMSO (or other appropriate solvent) stock and dilute into the target buffer/media with mixing to avoid precipitation. Maintain consistent final solvent % v/v across all samples and controls.
Green Alternatives

While this item is a discrete small molecule (not a solvent or reagent class with direct “green” substitutes), greener handling can be implemented in solvent choice and assay workflows.

Greener handling strategies (general):

  • Prefer aqueous-compatible stocks: if the compound dissolves in ethanol or aqueous cosolvent systems, these may be preferable to DMF or NMP from a green chemistry standpoint.
  • Minimize DMSO/DMF volumes: prepare higher-concentration stocks to reduce total organic solvent used and generated as waste, while ensuring solubility and assay tolerance.
  • Use low-toxicity, low-VOC options for cleaning and glassware rinsing (e.g., EtOH, i-PrOH) instead of chlorinated solvents, where compatible.
  • Scale prudently: right-size assay volumes and plate formats (384- or 1536-well) to reduce chemical consumption and waste.

Illustrative comparison (general, not item-specific):

  • DMSO vs DMF/NMP: DMSO typically offers better biocompatibility and a more favorable EHS profile than DMF or NMP. Choose DMSO when performance is equivalent.
  • Ethanol vs acetonitrile for intermediate dilutions: ethanol is often preferable environmentally, but check assay and compound compatibility (protein denaturation risk, solubility limits).

Documentation:

  • Track solvent selection rationale and disposal routes. Where feasible, adopt solvent recycling for high-volume steps and segregate halogenated from non-halogenated waste streams.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation specifications are provided for this item. It is supplied strictly for research use only.

General research/manufacturing context (non-clinical, literature/general):

  • Reference material: may be used as an internal research reference or system suitability control in microbiological assays once characterized in-house (identity, purity, potency under your conditions).
  • Preformulation screening: if structure permits, basic solubility, stability (pH/oxidative/light), and permeability measurements can support SAR and discovery-stage developability assessments.
  • Not for human or veterinary use; not GMP-produced unless explicitly stated on the CoA/Spec Sheet.

Item-specific statements:

  • Therapeutic claims are not made for this product.
  • Any use in regulated settings would require qualification against appropriate standards and documentation. None are specified for this item; consult the CoA/Spec Sheet if needed.
Physical Properties

Item-specific physicochemical data are not provided for this listing.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable for solids; otherwise not specified.

General laboratory guidance (literature/general, not item-specific):

  • For small-molecule screening compounds of unknown solubility, initial stock preparation in anhydrous DMSO (10–50 mM) is common; follow with serial dilution into assay buffer/media keeping final DMSO ≤0.5–1% v/v to minimize solvent effects.
  • If precipitation is observed on dilution, consider co-solvent strategies (DMSO → aqueous buffer with 0.01–0.05% non-ionic surfactant), warming to 37 °C, or sonication. Always verify final clarity before use.
  • If the compound is hygroscopic or polymorphic (unknown here), equilibrate to room temperature in a desiccator before opening to avoid moisture condensation.

Source labeling:

  • All numerical properties for this item are “Not specified” above; consult the CoA/Spec Sheet for definitive specifications.
Quality and Grades

Item-specific grade and purity are not listed for this product.

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpreting common grades (general guidance):

  • Screening library/research grade: typically supplied with LC–MS purity (often ≥90–95% by area) and identity confirmation (MS/NMR). Suitable for in vitro discovery assays; not intended for clinical use.
  • Analytical/AR grade: emphasizes low inorganic residue and defined assay content; may not control UV background or metal content for bioassays.
  • HPLC grade solvents vs compound purity: note that “HPLC grade” applies to solvents, not solids; for small molecules, look for “assay by HPLC,” “residual solvents,” and “water content (KF)” on the CoA.

What to check on the CoA/Spec Sheet for this item:

  • Purity method and result (e.g., HPLC/UPLC area%, GC, qNMR).
  • Identity confirmation (HRMS m/z, 1H/13C NMR, InChIKey).
  • Residual solvents and water content (Karl Fischer), if applicable.
  • Salt form, polymorph, or solvate state.
  • Batch-to-batch consistency and storage recommendations.

Stabilizers/inhibitors:

  • Not specified for this item; refer to CoA/Spec Sheet. If present, document their concentration and assess assay compatibility.
Reaction and Applications

This product is supplied as a small-molecule screening compound labeled “Antituberculosis agent-7.” It is not primarily intended as a synthetic reagent. Accordingly, classical organic reaction applications (e.g., cross-coupling, reductions) are not typically applicable without knowledge of functional groups.

Research applications (general, non-clinical):

  • Phenotypic screening against Mycobacterium spp. in vitro to identify antibacterial activity and prioritize chemotypes for SAR.
  • Biochemical/biophysical assays for target deconvolution (e.g., thermal shift, SPR, enzymatic inhibition) where relevant mycobacterial enzymes or pathways are under study.
  • Chemical proteomics or CETSA to probe protein engagement in mycobacterial lysates.
  • Combination testing with standard-of-care agents in checkerboard assays to explore potential synergy or antagonism (FICI analysis) in vitro.

Practical tips:

  • Prepare concentrated DMSO stocks and confirm clarity after dilution to assay conditions (monitor A600 scattering or visual inspection).
  • Control for solvent effects with matched DMSO vehicle controls at identical final % v/v.
  • Include sterility controls for microbiology assays and perform inoculum verification (CFU counts or OD calibration curves).

Note: No claims are made regarding potency, spectrum, or mechanism for this specific item; such properties must be established experimentally with the supplied lot and documented in your records.

Reaction Conditions

Classical reaction-condition guidance is not applicable because this product is supplied as a screening compound for biological research, not as a reagent or substrate for synthesis, and its functional groups are unknown.

General laboratory handling (literature/general):

  • Stock solution preparation: dissolve in anhydrous DMSO at 10–50 mM; vortex and, if needed, sonicate briefly. Confirm clarity and absence of particulates.
  • Dilution into assay media: add the organic stock to the aqueous phase with mixing; maintain final DMSO ≤0.5–1% v/v or per assay tolerance. Inspect for precipitation over assay time.
  • Stability checks: perform short-term stability by LC–MS/UPLC after incubation under assay conditions (e.g., 37 °C, relevant buffer) for the assay duration.

If the compound is to be used in chemistry (not typical here):

  • No recommended temperatures, catalysts, or solvents can be provided without structural information. Any such use must be developed de novo with appropriate small-scale trials and analytics.
Safety and Handling

Safety details specific to this item are not provided; handle conservatively as a research chemical of unknown hazard profile.

Item-specific safety data:

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification: Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.
  • Research Use: For research use only.

General laboratory precautions (literature/general):

  • Use in a chemical fume hood with standard PPE: lab coat, safety glasses, appropriate chemically resistant gloves (e.g., nitrile), and closed shoes.
  • Avoid inhalation, ingestion, and skin/eye contact. Prevent aerosolization when weighing or aliquoting.
  • Incompatibilities are unknown; segregate from strong oxidizers/reductants and acids/bases until specific data are available.
  • First aid (overview; defer to SDS): rinse eyes/skin with water for ≥15 min upon contact, remove contaminated clothing, and seek medical attention if irritation persists; if inhaled, move to fresh air; if ingested, do not induce vomiting—seek medical care.
  • Spill response: cover with inert absorbent, collect for disposal, and decontaminate area. Avoid release to the environment.
  • Waste: dispose of according to institutional hazardous waste procedures; do not combine with incompatible waste streams.

Authoritative source: Always consult the item-specific Safety Data Sheet (SDS) accompanying the lot for definitive hazard, exposure, and first-aid guidance.

Solvent Selection

Because the chemical structure and solubility parameters are not specified, select solvents using a conservative, assay-friendly strategy common for screening compounds.

General guidance (literature/general):

  • Primary stock solvent: anhydrous DMSO (10–50 mM) is the default for discovery libraries due to broad solvating power and biological compatibility at ≤0.5–1% v/v in assays.
  • Secondary solvents for pre-dissolution (if DMSO is insufficient): DMF, NMP, or co-solvent blends (DMSO:MeOH or DMSO:ACN). Validate assay tolerance to these co-solvents.
  • Aqueous workup: dilute DMSO stocks into buffer (e.g., PBS, HEPES, or assay-specific media) with gentle mixing; add compound solution to buffer, not vice versa, to reduce localized supersaturation.
  • pH considerations: for ionizable compounds (unknown here), adjust buffer pH to favor solubility of the predominant ionic form, but ensure biological relevance for the assay.

Comparison of common stock solvents (general):

  • DMSO: highest success rate for diverse chemotypes; low UV cutoff; biocompatible at low %.
  • DMF/NMP: strong solvents but less favored in cells/enzymes; use sparingly.
  • MeOH/EtOH: good for some neutral/lipophilic molecules; tighter limits in biology assays (≤0.2–0.5% v/v typically).

Documentation:

  • Record solvent, lot, final % in assay, and any observed precipitation or turbidity. Filter (0.2 µm PTFE) only if compatible and not adsorptive for the compound.
Storage and Reconstitution

Item-specific conditions:

  • Storage Conditions: Store at -20°C.
  • Shipped In: Ice chest + Ice pads.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution guidance for small-molecule screening compounds (literature/general):

  • Equilibrate the sealed container to room temperature before opening to avoid moisture condensation. If moisture sensitivity is suspected, handle under dry air or nitrogen.
  • Prepare a concentrated stock in anhydrous DMSO (typ. 10–50 mM). Vortex to dissolve; brief sonication and gentle warming (≤37 °C) may assist. Document final concentration.
  • Sterile filtration (0.2 µm PTFE) can be used if compatible and if biological sterility is required; verify no adsorption or degradation.
  • Aliquot stocks into single-use portions to avoid repeated freeze–thaw. Store aliquots at -20 °C (or as otherwise indicated on the CoA) in tightly sealed, chemically compatible vials.

Stability considerations:

  • Protect from light if chromophores are suspected; use amber vials/foil wrap. Minimize exposure to air and moisture.
  • Assess freeze–thaw stability by LC–MS/UPLC after representative cycles.

Thawing and use:

  • Thaw aliquots at room temperature, mix to homogeneity, and immediately dilute into assay buffer/media. Discard any precipitate or turbid solutions.

Definitive instructions, including any aqueous solubility limits or known instabilities, are Not specified for this item; refer to CoA/Spec Sheet.

Structure and Identity

Concise overview of catalog identity and any available structural identifiers for this screening compound.

  • SKU: A1417372
  • Product Name: Antituberculosis agent-7 (screening compound; small-molecule library member)
  • CAS: 2874263-73-5
  • Category Path: 全部 / 可售 / 小分子和化合物库
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general statement):

  • Specific ring systems, functional groups, and stereochemistry are not provided for this catalog entry. Without a structure, no detailed 2D/3D description can be given. Refer to the CoA/Spec Sheet for definitive identifiers.

Notes on identity confirmation (general best practice for screening compounds):

  • Verify identity by orthogonal methods when feasible (e.g., HRMS, 1H/13C NMR, LC–MS purity profile) before critical studies.
  • Assign an internal reference code linking your vial to CAS and SKU to maintain traceability across assays and passages.

Labeling of information sources:

  • Item-specific facts above are taken from Product Data. Any additional structural data should be taken from the item’s CoA/Spec Sheet or SDS once available.
Synthetic Utility

This product is a finished small-molecule screening compound rather than a functionalized building block. Without structural information (functional groups, handles), synthetic transformations or retrosynthetic applications cannot be recommended.

General note (literature/general):

  • If subsequent analogue synthesis is desired for SAR, first elucidate or obtain the structure and identify modifiable positions (e.g., halogens, heteroaryl nitrogens, side chains). Common diversification tactics include late-stage amide coupling, heteroaryl cross-coupling (Suzuki–Miyaura, Buchwald–Hartwig), or alkyl/aryl C–H functionalization, contingent on the core scaffold.
  • Protecting-group considerations, chemoselectivity, and stability (acid/base/oxidation) depend on the actual structure and must be established experimentally.

Item-specific caveat:

  • No functional-group data are available for this lot; consult the CoA/Spec Sheet or contact Technical Support for additional structural details if synthetic follow-up is intended.
Target Specificity

No target, enzyme, pathway, or binding specificity is provided for this item.

Item-specific data:

  • Target/epitope/clone/isotype: Not applicable to small molecules and not specified for this item.

General guidance (literature/general):

  • To explore target specificity experimentally, consider: resistant mutant selection and whole-genome sequencing, CRISPRi knockdown hypersensitivity profiling, chemical proteomics/affinity capture (if a handle can be introduced), or thermal shift/SPR with candidate proteins.

All conclusions about specificity must be derived from your own data; none are implied by this listing.

Foire aux questions

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2874263-73-5, the molecular formula is C26H19F4NO3, and the molecular weight is 469.43 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.